Trend of fluctuations of antithrombin in plasma of patients with COVID-19: a meta-analysis and systematic review

References

• WHO. WHO coronavirus disease (COVID-19) dashboard 2022. Available from: https://covid19.who.int/
   Google Scholar
• Falasca L, Agrati C, Petrosillo N, et al. Molecular mechanisms of Ebola virus pathogenesis: focus on cell death. Cell Death Differ. 2015 Aug 01;22(8):1250–1259.
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr;18(4):844–847.
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004 Jun 8;109(22):2698–2704.
   PubMed Web of Science ®Google Scholar
• Levi M, Hunt BJ. Thrombosis and coagulopathy in COVID-19: an illustrated review. Res Pract Thromb Haemost. 2020;4(5):744–751.
   PubMedGoogle Scholar
• Fox SE, Akmatbekov A, Harbert JL, et al. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020 Jul;8(7):681–686.
   PubMed Web of Science ®Google Scholar
• Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review.Expert Rev Hematol. 2020 Nov 01;13(11):1265–1275.
   PubMed Web of Science ®Google Scholar
• Mehrdad R, Zahra K, Mansouritorghabeh H. Hemostatic system (fibrinogen level, D-Dimer, and FDP) in severe and non-severe patients with COVID-19: a systematic review and meta-analysis. Clin App Thrombosis/Hemostasis. 2021 Jan 01;27:10760296211010973.
   Google Scholar
• Rostami M, Mansouritorghabeh H, Parsa-Kondelaji M. High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis. Clin Exp Med. 2021 Nov;6:1–11.
   Google Scholar
• Health NIo. National heart lung, and blood institute. study quality assessment tools. Bethesda: MD: National Institutes of Health; 2018.
   Google Scholar
• Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–1805.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):1–13.
   PubMedGoogle Scholar
• Corral J, de la Morena-Barrio ME, Vicente V. The genetics of antithrombin. Thromb Res. 2018 Sep;169:23–29.
   PubMed Web of Science ®Google Scholar
• Van Cott EM, Orlando C, Moore GW, et al., Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH. J Thromb Haemost. 2020;18(1):17–22.
   PubMedGoogle Scholar
• Vossen CY, Conard J, Fontcuberta J, et al., Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost. 2004;2(9):1526–1532.
   PubMedGoogle Scholar
• Khor B, Van Cott EM. Laboratory tests for protein C deficiency. Am J Hematol. 2010;85(6):440–442.
   PubMedGoogle Scholar
• Rosenberg RD, Boro ES, Rosenberg RD. Actions and interactions of antithrombin and heparin. N Engl J Med. 1975 Jan 16;292(3):146–151.
   PubMed Web of Science ®Google Scholar
• Jin L, Abrahams JP, Skinner R, et al. The anticoagulant activation of antithrombin by heparin. Proc Nat Acad Sci. 1997;94(26):14683–14688.
   PubMedGoogle Scholar
• Stern D, Nawroth P, Marcum J, et al. Interaction of antithrombin III with bovine aortic segments. role of heparin in binding and enhanced anticoagulant activity. J Clin Invest. 1985 Jan;75(1):272–279.
   PubMedGoogle Scholar
• White D, MacDonald S, Bull T, et al. Heparin resistance in COVID-19 patients in the intensive care unit. J Thromb Thrombolysis. 2020 Aug;50(2):287–291.
   PubMed Web of Science ®Google Scholar
• Iba T. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers. J Thromb Haemost. 2015;13(4):682–683.
   PubMedGoogle Scholar
• Tagami T, Matsui H, Horiguchi H, et al. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost. 2014;12(9):1470–1479.
   PubMed Web of Science ®Google Scholar
• Hayakawa M, Kudo D, Saito S, et al. Antithrombin supplementation and mortality in sepsis-induced disseminated intravascular coagulation: a multicenter retrospective observational study. Shock. 2016 Dec;46(6):623–631.
   PubMed Web of Science ®Google Scholar
• Tabatabai A, Rabin J, Menaker J, et al. Factor VIII and functional protein c activity in critically Ill patients with coronavirus disease 2019: a case series [Article]. A A Pract. 2020;14(7):e01236.
   PubMedGoogle Scholar
• Panigada M, Bottino N, Tagliabue P, et al., Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis [Article]. J Thromb Haemost. 2020;18(7):1738–1742.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cao W, Jiang W, et al. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients [Article]. J Thromb Thrombolysis. 2020;50(3):580–586.
   PubMed Web of Science ®Google Scholar
• Hardy M, Michaux I, Lessire S, et al. Prothrombotic hemostasis disturbances in patients with severe COVID-19: individual daily data. Data Brief. 2020 Dec 33;33:106519.
   PubMed Web of Science ®Google Scholar
• Gerotziafas GT, Sergentanis TN, Voiriot G, et al. Derivation and validation of a predictive score for disease worsening in patients with COVID-19 [Article]. Thromb Haemost. 2020;120(12):1680–1690.
   PubMedGoogle Scholar
• Boscolo A, Spiezia L, Correale C, et al. Different hypercoagulable profiles in patients with COVID-19 admitted to the internal medicine ward and the intensive care unit. Thromb Haemost. 2020;120(10):1474–1477.
   PubMed Web of Science ®Google Scholar
• Goshua G, Pine AB, Meizlish ML, et al., Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study [Article]. Lancet Haematol. 2020;7(8):e575–e582.
   PubMed Web of Science ®Google Scholar
• Nougier C, Benoit R, Simon M, et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis [Article]. J Thromb Haemost. 2020;18(9):2215–2219.
   PubMed Web of Science ®Google Scholar
• von Meijenfeldt FA, Havervall S, Adelmeijer J, et al. Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality. Res Pract Thromb Haemost. 2021 Jan;5(1):132–141.
   PubMedGoogle Scholar
• Liu J, Liu Z, Jiang W, et al. Clinical predictors of COVID-19 disease progression and death: analysis of 214 hospitalised patients from Wuhan, China [Article]. Clin Respir J. 2021;15(3):293–309.
   PubMedGoogle Scholar
• White D, MacDonald S, Edwards T, et al. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays [Article]. Int J Lab Hematol. 2021;43(1):123–130.
   PubMedGoogle Scholar
• Li G, Du L, and Cao X, et al. Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients [Article]. BMC Infect Dis. 2021;21(1):1–10.
   PubMedGoogle Scholar
• Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020;7(9):e671–e678.
   PubMed Web of Science ®Google Scholar
• Gazzaruso C, Paolozzi E, Valenti C, et al., Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity [Article]. Nutr Metab Cardiovasc Dis. 2020;30(11):1914–1919.
   PubMed Web of Science ®Google Scholar
• Briguglio M, Crespi T, and Pino F, et al. Clinical characteristics of severe COVID-19 patients admitted to an intensive care unit in Lombardy during the Italian pandemic [article]. Front Med. 2021;8:582896.
   Google Scholar
• Martín-Rojas RM, Pérez-Rus G, Delgado-Pinos VE, et al., COVID-19 coagulopathy: an in-depth analysis of the coagulation system [Article]. Eur J Haematol. 2020;105(6):741–750.
   PubMedGoogle Scholar
• Anaklı İ, Ergin Özcan P, Polat Ö, et al. Prognostic value of antithrombin levels in COVID-19 patients and impact of fresh frozen plasma treatment: a retrospective study. Turk J Haematol. 2021 Feb 25;38(1):15–21.
   PubMedGoogle Scholar
• Liu Y, Gao W, Guo W, et al. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19 [Article]s. J Thromb Thrombolysis. 2020;50(4):825–832.
   PubMedGoogle Scholar
• Sehgal T, Gupta N, Kohli S, et al. A prospective study of specialized coagulation parameters in admitted COVID-19 patients and their correlation with acute respiratory distress syndrome and outcome. Cureus. 2021 Aug;13(8):e17463.
   PubMedGoogle Scholar
• Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure [article]. Thromb Haemost. 2020;120(6):998–1000.
   PubMed Web of Science ®Google Scholar
• Zhang Y, He L, Chen H, et al. Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: retrospective analysis [Article]. Int J Lab Hematol. 2020;42(6):766–772.
   PubMedGoogle Scholar
• Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection [Article]. Clin Chem Lab Med. 2020;58(7):1116–1120.
   PubMed Web of Science ®Google Scholar
• von Meijenfeldt FA, Havervall S, Adelmeijer J, et al., Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge [Letter]. Blood Adv. 2021;5(3):756–759.
   PubMedGoogle Scholar
• Umemura Y, Yamakawa K, Kiguchi T, et al. Hematological phenotype of COVID-19-induced coagulopathy: far from typical sepsis-induced coagulopathy [Article]. J Clin Med. 2020;9(9):1–11.
   Google Scholar
• Al Otair H, AlSaleh K, AlQahtany FS, et al. The level of vWF antigen and coagulation markers in hospitalized patients with Covid-19. J Blood Med. 2021;12:809–817.
   PubMed Web of Science ®Google Scholar
• Belikina DV, Malysheva ES, Petrov AV, et al. COVID-19 in patients with diabetes: clinical course, metabolic status, inflammation, and coagulation disorder [Article]. Sovrem Tehnol Med. 2020;12(5):6–18.
   PubMedGoogle Scholar
• Cheng B, Jiang T, Zhang L, et al. Clinical characteristics of pregnant women with coronavirus disease 2019 in Wuhan, China [Article]. Open Forum Infect Dis. 2020;7(8). DOI:10.1093/ofid/ofaa294.
   Google Scholar